AE, adverse event; MAIC, matching-adjusted indirect comparison; mDOR, median duration of response; METex14, mesenchymal epithelial transition factor exon 14; mOS, median overall survival; mPFS, median progression-free survival; NSCLC, non-small cell lung cancer; QoL, quality of life